European Medicines Evaluation Agency Starts Safety Probe Of Common Bone Drugs Made by Roche, Merck & Co., Inc., Novartis AG and Warner Chilcott, PLC

LONDON, Sept 24 (Reuters) - European drugs regulators said they had started a safety review of a class of osteoporosis bone drugs called bisphosphonates after studies suggested a possible link to stress fractures.